GENRegulatory•globenewswire•
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)
Sentiment:Positive (70)
Summary
Media Release COPENHAGEN, Denmark; August 26, 2025
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 26, 2025 by globenewswire